EAGLE PHARMACEUTICALS INC (EGRX) Institutional Ownership Changes & 13F Activity
EAGLE PHARMACEUTICALS INC (EGRX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period.
No data available.
Frequently asked questions about EGRX activity
Which institutional owners are buying EGRX?
Institutional owners buying EGRX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in EGRX activity?
"Buy" means an investor increased their reported position in EGRX compared to the prior reporting period. This reflects growing exposure to EAGLE PHARMACEUTICALS INC (EGRX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in EGRX increasing?
Institutional interest in EGRX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related EGRX Institutional Insights
- EGRX Overview
- EGRX 13F Institutional Holders
- EGRX Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- EGRX Insider Trading & SEC Form 4 Activity
- EGRX Articles
- Top Institutional Investor Stock Rankings